Drug Interactions between Proben-C and Tazicef Novaplus
This report displays the potential drug interactions for the following 2 drugs:
- Proben-C (colchicine/probenecid)
- Tazicef Novaplus (ceftazidime)
Interactions between your drugs
No interactions were found between Proben-C and Tazicef Novaplus. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Proben-C
A total of 435 drugs are known to interact with Proben-C.
- Proben-c is in the drug class antigout agents.
- Proben-c is used to treat Gouty Arthritis.
Tazicef Novaplus
A total of 57 drugs are known to interact with Tazicef Novaplus.
- Tazicef novaplus is in the drug class third generation cephalosporins.
-
Tazicef novaplus is used to treat the following conditions:
- Bacteremia
- Bladder Infection
- Bone infection
- Endocarditis
- Endometritis
- Febrile Neutropenia
- Intraabdominal Infection
- Joint Infection
- Kidney Infections
- Melioidosis
- Meningitis
- Middle Ear Infections
- Nosocomial Pneumonia
- Otitis Externa
- Pelvic Inflammatory Disease
- Peritonitis
- Pneumonia
- Pneumonia with Cystic Fibrosis
- Sepsis
- Septicemia
- Sinusitis
- Skin and Structure Infection
- Skin or Soft Tissue Infection
- Urinary Tract Infection
Drug and food interactions
colchicine food
Applies to: Proben-C (colchicine / probenecid)
Drinking large amounts of grapefruit juice can increase your blood levels of colchicine to dangerous levels. You should avoid the consumption of grapefruit or grapefruit juice during treatment with colchicine. Let your doctor know if you experience abdominal pain, nausea, vomiting, diarrhea, fever, muscle pain, weakness, fatigue, and/or numbness or tingling in your hands and feet, as these may be early symptoms of colchicine toxicity.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.